Medical device manufacturer in US signs contract with ClinFlows’ to manage TAVI proctoring activities online.
Californian proctoring coordination group uses decidemedical platform
Hüllhorst, Germany, December 16, 2014— The Californian based coordination group for proctoring activities in the field of Trans Aortic Valve Implantation (TAVI) from a major player in the cardiovascular market, signed a contract with Germany based company ClinFlows. The US team will use ClinFlows’ decidemedical platform to manage the review of TAVI candidates from South America (SA) to assure patients eligibility based on medical images (DICOM) uploaded by SA hospitals. The EU division of this medical device maker is already using ClinFlows’ solution since many years. “The expansion to US reflects our clients’ satisfaction and reliability of our solution, which is used in 66 countries worldwide”, says Uwe Gladbach, ClinFlows’ Managing Director.
ClinFlows’ decidemedical online platform supports patient screening and eligibility processes in various clinical projects. Automated notifications and communication tools are seamlessly integrated, offering a complete solution to manage clinical data and medical images to be shared in multiple clinical scenarios.
ClinFlows is focused on the management, development and maintenance of Software as a Service (SaaS) based clinical workflow management solutions for clinical workflows, supporting clinical trials, product launch activities, medical case reviews by experts and physician online training scenarios. The decidemedical platform enables all stakeholders of clinical workflows to share cases quickly, easily and securely. ClinFlows simplifies the process of transferring large amount of medical images (DICOM) and clinical data between hospitals, institutes and specialist around the world, and facilitates collaboration on clinical cases through specific discussion tools around medical images and clinical data. ClinFlows customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes global healthcare companies. The decidemedical platform is utilised in 66 countries worldwide.